Geode Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-682,043
| Closed | -$73.2M | – | 4812 |
|
|
2023
Q1 | $73.2M | Buy |
682,043
+35,396
| +5% | +$3.8M | 0.01% | 930 |
|
|
2022
Q4 | $71.1M | Buy |
646,647
+110,263
| +21% | +$12.1M | 0.01% | 909 |
|
|
2022
Q3 | $31.7M | Buy |
536,384
+172,329
| +47% | +$10.2M | ﹤0.01% | 1414 |
|
|
2022
Q2 | $10.3M | Sell |
364,055
-20,060
| -5% | -$566K | ﹤0.01% | 2231 |
|
|
2022
Q1 | $14.5M | Buy |
384,115
+17,477
| +5% | +$660K | ﹤0.01% | 2101 |
|
|
2021
Q4 | $14.5M | Buy |
366,638
+151,464
| +70% | +$5.99M | ﹤0.01% | 2184 |
|
|
2021
Q3 | $5.1M | Buy |
215,174
+4,562
| +2% | +$108K | ﹤0.01% | 2908 |
|
|
2021
Q2 | $5.17M | Buy |
210,612
+192,840
| +1,085% | +$4.74M | ﹤0.01% | 2879 |
|
|
2021
Q1 | $324K | Buy |
+17,772
| New | +$324K | ﹤0.01% | 3962 |
|